Actuate Therapeutics Inc (ACTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -22,228 | -27,285 | -24,745 |
| Accounts payable and accrued liabilities | -513 | -1,501 | 1,291 |
| Other Working Capital | -3,045 | 1,100 | 2,573 |
| Other Operating Activity | 6,579 | 5,843 | -744 |
| Operating Cash Flow | $-19,206 | $-21,843 | $-21,625 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | 200 | N/A |
| Debt Issued | N/A | 5,500 | N/A |
| Common Stock Issued | 24,027 | 23,957 | N/A |
| Other Financing Activity | -303 | -2,131 | 4,135 |
| Financing Cash Flow | $23,724 | $27,526 | $4,135 |
| Beginning Cash Position | 8,642 | 2,959 | 20,449 |
| End Cash Position | 13,159 | 8,642 | 2,959 |
| Net Cash Flow | $4,518 | $5,683 | $-17,491 |
| Free Cash Flow | |||
| Operating Cash Flow | -19,206 | -21,843 | -21,625 |
| Free Cash Flow | -19,206 | -21,843 | -21,625 |